Tenaya Therapeutics, Inc. (NASDAQ: TNYA) is a Healthcare company (Biotechnology) with a market capitalization of $74M. The Maz Rating grades it against the other companies in its sector.
Tenaya Therapeutics, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $0.32, Tenaya Therapeutics, Inc. trades at 24.1x sales and 1.3x book value. Over the last twelve months it generated about $3M of revenue and a net loss of $113M. It runs an operating margin of -3446.6% and a net margin of -3356.8%. It shows return on equity of -115.2%, return on invested capital of -173.3% and a free cash flow yield of -100.4%. On the balance sheet: a debt-to-equity ratio of 0.05 and a current ratio of 3.78. Over the past 52 weeks the share price ranged from $0.30 to $1.46, with a beta of 2.88.
Tenaya Therapeutics, Inc. does not currently pay a dividend.
6 Wall Street analyst ratings cover the stock: 6 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.